Article Information
History
- May 11, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Makenga Bof Jean Claude1,*,
- Mansiangi Paul2,†,
- Zanga Josué2,
- Ilunga Félicien3,
- Ako Aime Gilles Adjami4,
- Sanfo Moussa Sounkalo4,
- Didier Bakajika4 and
- Coppieters Yves1
- 1School of Public Health, Université Libre de Bruxelles (ULB), Route de Lennik 808, 1070 Brussels, Belgium
- 2School of Public Health, Faculty of medicine, Université de Kinshasa ((UNIKIN), Lemba, Kinshasa, DRC)
- 3Institut Supérieur des Techniques Médicales (ISTM), Lemba, Kinshasa, DRC
- 4Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN), WHO, Brazzaville, Republic of Congo
- ↵*Corresponding author
Makenga Bof Jean Claude, Ecole de Santé Publique, Université Libre de Bruxelles (ULB), Route de Lennik 808, 1070 Brussels, Belgium., Mobile: +32 493 93 96 35, Email: jcmakebof{at}yahoo.fr
Posted May 11, 2023.
Ongoing transmission of human onchocerciasis in the district of Mont Ngafula 1 in Kinshasa after two decades of uninterrupted onchocerciasis annual mass campaigns using community directed treatment with Ivermectin strategy
